JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Начало・Списък с акции・Owens & Minor Inc

Owens & Minor Inc

Затворен

СекторЗдравеопазване

3.45 -11.31

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.4

Максимум

3.89

Ключови измерители
By Trading Economics
Приходи	-59M -84M
Продажби	-2B 682M
Марж на печалбата	-12.292
Служители	20,000
EBITDA	-100M -40M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+45.59% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	69M 423M
Предишно отваряне	14.76
Предишно затваряне	3.45

Настроения в новините

By Acuity

100%

360 / 373 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

6.98 / 7.075 Подкрепа & съпротива

Owens & Minor Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.11.2025 г., 21:44 ч. UTC

Печалби

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3.11.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3.11.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3.11.2025 г., 23:28 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3.11.2025 г., 23:24 ч. UTC

Печалби

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3.11.2025 г., 23:12 ч. UTC

Печалби

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3.11.2025 г., 23:06 ч. UTC

Пазарно говорене

Печалби

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3.11.2025 г., 22:36 ч. UTC

Пазарно говорене

Печалби

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q EPS $1.49 >FNV

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q Rev $487.7M >FNV

3.11.2025 г., 22:24 ч. UTC

Пазарно говорене

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3.11.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Starbucks Agrees to Sell Stake in China Business -- WSJ

3.11.2025 г., 21:59 ч. UTC

Пазарно говорене

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене

Печалби

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

3.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

3.11.2025 г., 21:49 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3.11.2025 г., 21:40 ч. UTC

Печалби

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3.11.2025 г., 21:31 ч. UTC

Пазарно говорене

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3.11.2025 г., 21:19 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3.11.2025 г., 21:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3.11.2025 г., 21:11 ч. UTC

Печалби

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3.11.2025 г., 21:07 ч. UTC

Печалби

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3.11.2025 г., 21:05 ч. UTC

Печалби

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3.11.2025 г., 21:05 ч. UTC

Печалби

Palantir Technologies 3Q Net $475.6M >PLTR

Сравнение с други в отрасъла

Ценова промяна

Owens & Minor Inc Прогноза

Ценова цел

By TipRanks

45.59% нагоре

12-месечна прогноза

Среден 5.78 USD 45.59%

Висок 7 USD

Нисък 4 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Owens & Minor Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Owens & Minor Inc през последните 3 месеца.

Техническа оценка

By Trading Central

6.98 / 7.075Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bullish event.

All events are bearish.

Настроение

By Acuity

360 / 373 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Owens & Minor Inc

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.